CROSSOVERS IN CORONARY-ARTERY BYPASS-GRAFTING TRIALS - DESIRABLE, UNDESIRABLE, OR BOTH

被引:5
作者
FISHER, LD
KAISER, GC
DAVIS, KB
MOCK, MB
机构
[1] UNIV WASHINGTON,COORDINATING CTR COLLABORAT STUDIES CORONARY ARTERY SURG,SEATTLE,WA 98105
[2] ST LOUIS UNIV,SCH MED,ST LOUIS,MO 63104
[3] MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905
关键词
D O I
10.1016/S0003-4975(10)66840-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:465 / 466
页数:2
相关论文
共 9 条
[1]  
FISHER LD, IN PRESS PHARM DRUG
[2]  
KAISER GC, 1985, J THORAC CARDIOV SUR, V89, P513
[3]   12-YEAR FOLLOW-UP OF SURVIVAL IN THE RANDOMIZED EUROPEAN CORONARY SURGERY STUDY [J].
VARNAUSKAS, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (06) :332-337
[4]   EFFECT OF CROSSOVER ON THE STATISTICAL POWER OF RANDOMIZED STUDIES [J].
WEINSTEIN, GS ;
LEVIN, B .
ANNALS OF THORACIC SURGERY, 1989, 48 (04) :490-495
[5]  
1983, CIRCULATION, V68, P951
[6]  
1983, CIRCULATION, V68, P939
[7]  
1981, CIRCULATION S2, V63, P1
[8]  
1984, J AM COLL CARDIOL, V3, P114
[9]  
1984, NEW ENGL J MED, V311, P1333